GlassScriptPhysician profile
Joshua Rice
NPI 1164503744
$6,558.35
in general payments reported to CMS, 2019-2025
32 companies · $1,730 in 2025
The $1,730 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $416 · 2021: $421 · 2022: $418 · 2023: $1,339 · 2024: $1,950 · 2025: $1,730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,001 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,001.31 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,241.83 | 2020-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Glaxosmithkline, LLC. | $1,180.96 | 2023-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $753.56 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Insmed, INC. | $433.18 | 2022-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $273.24 | 2022-2025 | Dupixent |
| Genzyme Corporation | $216.75 | 2022-2025 | |
| Pfizer INC. | $195.90 | 2019-2021 | |
| Grifols USA, LLC | $192.74 | 2019-2024 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $191.99 | 2020-2024 | Yupelri |
| Inari Medical, INC. | $189.75 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $172.49 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Cvrx, INC. | $169.05 | 2024 | Barostim Neo System |
| Electromed, INC. | $143.04 | 2024-2025 | Smartvest |
| United Therapeutics Corporation | $138.70 | 2023-2025 | Tyvaso, Tyvaso |
| Advanced Respiratory, INC | $123.90 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $123.70 | 2025 | Yupelri |
| Philips North America LLC | $121.14 | 2020-2025 | (Ak6) Vest Therapy, Disposable Vest |
| Mallinckrodt Hospital Products INC. | $114.25 | 2021-2023 | Acthar |
| Baxter Healthcare | $105.25 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Janssen Pharmaceuticals, INC | $90.41 | 2022-2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $75.89 | 2020-2023 | Uptravi, Opsumit |
| Shionogi INC | $45.19 | 2021-2023 | Fetroja |
| Genentech USA, INC. | $43.00 | 2019 | |
| Paratek Pharmaceuticals, INC. | $40.81 | 2023-2024 | Nuzyra |
| Intuitive Surgical, INC. | $30.61 | 2024 | |
| Portola Pharmaceuticals, LLC | $27.87 | 2019 | |
| Abbvie INC. | $27.19 | 2022 | |
| La Jolla Pharmaceutical Company | $26.21 | 2023 | Giapreza |
| Otsuka America Pharmaceutical, INC. | $23.67 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.85 | 2024 | |
| Pulmonx Corporation | $16.75 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| E.R. Squibb & Sons, L.L.C. | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.